APG-1387 is a novel small molecule IAP inhibitor (Inhibitor of Apoptosis Protein).
|Developed By||Ascentage Pharma Group Inc.|
View all active clinical trials around the US.
The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.
There are no resources, links or videos to display for this treatment.